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Abstract
Purpose: Glomus tumours are characteristically benign solitary tumours. At our knowledge, about 23 reports are present in
literature regarding the malignant counterpart, but only a minority developed metastases. We describe a locally aggressive
glomus tumour with lymphnode metastasis.
Patient: The patient was a 40 year-old man presenting a 1.5-cm lesion on the right wrist incompletely excised and a recurrent
tumour, 4 2cm in size, removed after 9 months, for which he received radiotherapy. After 2 years he developed an axillary
lymphnode metastasis.
Results: Histologically, both tumours (primary and metastasis) were similar. There were sheets and nests of uniform small
cells with scant eosinophilic cytoplasm and round to polygonal nuclei; there was some degree of pleomorphism and the
mitotic index was high (up to 18m/10HPF). The tumour cells were positive for vimentin and smooth muscle actin, but
negative for desmin, NSE, Factor VIII, chromogranin, cytokeratin. Remarkably, in the primary, the cells strongly expressed
p53 (70%) and MIB-1 (35%).
Discussions: In many reported malignant cases, the histology of the tumour cells suggested that they were malignant, yet the
clinical course has been benign. Carefully reviewing the literature, it seems that actually we have enough histological criteria
to identify the cases with biological adverse outcome. Those unfortunate cases behave as high grade sarcomas and therefore
may deserve an aggressive therapeutic treatment.
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Introduction
Glomustumours(GT) are relatively uncommon
lesions with an estimated incidence of about 1%
among soft tissue tumours.
1 Usually they occur as
solitary or even multicentric lesions, in the deep
dermisor s ubcutisof the upper or lower extremity,
with the most common location in the subungual
region of the finger.
1 Unusual locations are also
reported, including mediastinum and respiratory
tract,
2–4 gastrointestinal tract,
5 gynecological
regions.
1
Glomustumoursare benign in the overtly majority
of the cases. However, glomus tumours can show
aggressive and/or malignant clinical and histological
features. These atypical glomus tumours were classi-
fied in three different categoriesbas ed on architec-
tural and histological features:
6 locally infiltrative
glomus tumours (LIGT), glomangiosarcoma arising
within a glomustumour (GABG), and de novo
glomangiosarcoma (GADN). Following the morpho-
logical criteria, we were able to find 23 reportsof
malignant cases in literature.
1–4,6–24 Since most of
them did not metastasize, it is difficult to accept all
of them asmalignant tumoursin the fulles t meaning
of the word and some cases of local recurrence
probably represent persistence of the tumour follow-
ing inadequate excision.
1 A malignant counterpart
has been strongly questioned, since it was stated that
‘‘the malignant transformation is such a rare event
that it can be dismissed from a practical point of
view’’.
1 However, reviewing the literature carefully,
some metastatic cases were evident, often widespread
in a short time, proving that the malignant glomus
tumours (MGT) do really exist. A similar conclusion
hasbeen drawn from the authorsof a recently
published paper studying their large consultation
files.
24
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metastasizing to an axillary lymphnode after 2 years.
Our findingsare s imilar to the morphological and the
prognostic criteria proposed by Folpe et al. in their
extensive work.
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Clinical history
The patient wasa 40-year-old man pres enting a
1.5-cm lesion on the right wrist incompletely excised
and interpreted ashemangiopericytoma at another
institution. After 9 months he was referred to Napoli
NCI for a recurrent tumour. A 5 4-cm biopsy
showed a gray, non-encapsulated nodule, 4 2cmin
size, located in the deep dermis. At this time, we also
reviewed the slides from the original tumour. An
exhaustive clinical work up revealed no metastases.
Because of the histological diagnosis of a low-grade
sarcoma, the patient received a total dose of 56 Gy.
After 2 years, a FNAC on an enlarged axillary
lymphnode yielded a positive result. A complete
axillary dissection was performed which revealed
diffuse metastasis to one out of 29 lymphnodes. The
patient then received chemotherapy (epirubicin
120mg/m
2, ifosfamide 9g/m
2).
Histologically, the primary and the recurrent
tumour were both remarkably similar. There were
sheets and nests of uniform round or polygonal cells
infiltrating the reticular layer of the dermiswith
distinct cell borders and scant eosinophilic cyto-
plasm; there was some degree of pleomorphism and
the mitotic index washigh (up to 5mitos es /10HPF)
(Fig. 1). A spindle cells growth was focally present
(Fig. 2) and an hemangiopericytoma pattern wasals o
focally evident (Fig. 3). Moreover, the glomocytes
formed subendothelial masses that protruded into
the lumensof the venouschannelsand s mall tumour
noduleswere clearly intravas cular (Fig. 4). No
structure resembling a glomus body was observed.
Cytoplasmic positivity for vimentin and for smooth
muscle actin was present (Fig. 5). A pericellular
staining around cells with collagen type IV was also
seen. Other markers such as desmin, NSE, chromo-
granin, cytokeratin, EMA, Factor VIII were all
negative. Remarkably, the cells strongly expressed
p53 (70%) and MIB-1 (35%). Based on these
features, the case was considered to be a malignant
glomus tumour, that is, a glomangiosarcoma arising
de novo. The lymphnode showed similar histological
findings with some very large cavernous vessels
always surrounded by glomus cells and cystic
degeneration filled with proteinaceousmaterial
(Fig. 6).
Fig. 3. A prominent vascular component is always present
with features sometimes reminiscent of hemangiopericytoma
(H&E,  4).
Fig. 1. Neoplastic cells show round to oval nuclei with very
distinct cell borders. Note the small but evident nucleoli and the
mitotic figure (H&E,  20).
Fig. 4. The tumour (on left) presents clearly vascular space
involvement (on right) (H&E,  10).
Fig. 2. Focally an hypercellular spindle cells pattern is well
evident (H&E,  10).
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The glomus tumour is a distinct neoplasm composed
of perivascular cells resembling the modified smooth
muscle cells of the normal glomus body.
1 The
glomusbody isa s pecialized form of arterio-venous
anastomosis that serves in thermal regulation. It is
located in the stratum reticularis of the dermis and
is most frequently encountered in the subungual
region, the lateral areasof the digits , and the palm.
Istherefore in thos e areasthat the glomustumour is
mainly found. But the tumour can also be encoun-
tered in other sites where the normal glomus body
may be sparse or even absent,
1 such as mediastinum
and respiratory tract,
2–4 gastrointestinal tract,
5 gyne-
cological regions.
1 Usually they are solitary, painful,
well-circumscribed tumours, cured by simple exci-
sion. Multiple forms do also occur. They tend to
be asymptomatic, rarely subungual, and acquired
during the childhood.
Histologically, the glomus tumour is a well-
circumscribed lesion consisting of convoluted capil-
lary-sized vessels surrounded by glomus cells in a
hyalinized or myxoid stroma. The tumour may have
a highly vascular pattern reminiscent of a hemangio-
pericytoma. The cellsare monomorphouswith a
rounded, regular shape and somewhat cohesive,
giving them an epithelioid appearance.
Some cytologically benign tumoursare locally
infiltrative and tend to recur after simple excision.
6
They are usually larger and more deeply located than
the conventional ones. They may show a more
extensive solid growth pattern or cavernous gloman-
gioma pattern. These locally infiltrative glomus
tumours(LIGT) may therefore need a more
complete excision. The recognition of a malignant
counterpart hasbeen controvers ial. There are two
described categories: the first is a cytologically
malignant tumour arising and merging with a typical
glomustumour, des ignated glomangios arcoma in a
benign glomus(GABG)
14. In these cases the
malignant component shows mitotic figures and
cytologic atypia
6 or even hasfeaturesof a s pindle
cell sarcoma.
1,15,17 Such cytological atypia hasals o
been interpreted simply as an epitheliod change in an
otherwise typical glomus tumour similar to nuclear
variability present in other biologically benign
tumour such as collagenous fibroma of the skin,
ancient schwannoma and symplastic leiomyoma.
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Since none of these cases metastasized, the existence
of a MGT has strongly been questioned.
1 However,
the malignant areasprove to s how molecular
abnormalities such as increased bcl-2 and p53
expression, not present in the benign component or
in benign glomustumours(GT) asinternal con-
trol.
17,26 These results suggest that MGT may have a
potentially more aggressive behavior than benign
GTs.
The second malignant group, and more difficult to
recognize, is de novo glomangiosarcoma (GADN),
in which a benign glomuscomponent cannot be
identified. It is composed by undifferentiated small
round orovalcells,withvesicular nuclei, often promi-
nent nucleoli and scant cytoplasm, which grow in
large sheets; the mitotic index varies but it is always
well appreciated.
2,3,6,8,9,11,15,18,19,22 Thusthe
tumour must be distinguished from other round
cell sarcomas, or metastatic carcinoma because of the
overall epithelioid appearance. However, the diag-
nostic clue is that the cell population and the archi-
tecture closely resemble those of the benign glomus.
As a matter of fact, in at least some areas, the tumour
cellsinves t and intimately relate to ves s elslike its
benign counterpart. The immunostaining pattern for
glomustumours(actin pos itive, epithelial markers
negative) are helpful in the differential diagnosis. In
addition, glomustumourss how prominent inter-
cellular reticulin, laminin and collagen type IV
staining.
23,27
Confluent zones of necrosis are only occasionally
present.
23,24 A typical feature isindeed the pres ence
of pseudocysts of varying size often filled of
proteinaceous material, which seem to be the result
of cystic degeneration.
3,6,18,23 Most of the single
cases diagnosed as potentially malignant glomus
tumoursfall in the GADN category. However, only
eight of them metastasized.
7,8,10–12,18,22,23 In the
only large published series
24 based on 35 potentially
Fig. 6. The lymph node sections show a peripheral thin rim of
uninvolved tissue (on the left) and large hemorrhagic space
surrounded by neoplatsic cells similar to primary (H&E,  4).
Fig. 5. The neoplastic cells present strong smooth muscle actin
expression (immunoperoxidase,  10).
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patientswith follow-up was38% (eight out of 21
patients). The authors found that the adverse out-
come wasnotably related to deep location, s ize larger
than 2cm, and the presence of atypical mitotic
figures. However, some other features, including
necrosis, mitotic activity of more than five mitoses/
50HPF, and combination of high nuclear grade and
high mitotic activity showed a trend toward but
did not achieve statistical significance.
24 Asa matter
of fact, our patient, aswell ascas e no. 25 of their
series and the patient reported by Watanabe et al.,
22
showed high nuclear grade and high mitotic
activity and, even though superficial in location,
metastasized.
Vascular space involvement was observed in 10
cases,
11,24 and lymphnode metastases were present in
at least three patients.
11,18,24 Our case, interpreted as
GADN, also showed some intravascular tumour
nodulesand pres ented a metas tatic axillary lymph-
node after 2 years, despite radiotherapy having
achieved a local control of the disease. Therefore we
could hypothesize that the intavascular invasion is the
key feature for the metastatic potential of the MGT.
However, intravascular spread was also described in
one GABG of the stomach
5 and in one GADN of the
right thigh
19 that did not show recurrence or
metastasis after 7 and 57 months after surgery,
respectively. An alternative explanation is that the
intravascular spread in glomus tumour is analogous
to that observed in intravascular leiomyomatosis.
5
MGTs were usually believed low-grade sarco-
mas.
6,23 However, five out of eight metastatic
GADN (two of which located in the lung) showed
widespread metastases
10,11,18,22,23 in a few months
and rapidly died of the disease
10,18,23 despite chemo-
therapeutic regimens. In the series reported by
Folpe et al.,
24 of the eight patientswho developed
metastatic disease, six were dead in less than 3 years.
In conclusion, the malignant glomus tumours do
really exist and we have enough histological criteria
to identify them. They are probably high grade
sarcomas and should be treated as such.
Acknowledgements
The authorswis h to thank Mr. L. Iodice and Mr. A.
Barbato for their technical assistance.
References
1. Enzinger FM, Weiss SW. Soft Tissue Tumors. St. Louis,
MO: CV Mosby, 1995: 701–13.
2. Choi TJ, Yang KH, Gang SJ, Kim BK, Kim SM.
Malignant glomustumor originating in the s uperior
mediastinum: an immunohistochemical and ultrastruc-
tural study. J Korean Med Sci 1991; 6: 157–63.
3. Hirose T, Hasegawa T, Seki K, Yang P, Sano T,
Morizumi H, Tsuyuguchi M. Atypical glomus tumor in
the mediastinum: a case report with immunohistochem-
ical and ultrastructural studies. Ultrastruct Pathol 1996;
20: 451–6.
4. Gaertner E, Steinberg DM, Huber M, Hayashi T,
Tsuda N, Askin FB, Bell SW, Nguyen B, Colby TV,
Nishimura SL, Miettinen M, Travis WD. Pulmonary
and mediastinal glomus tumors. Report of five cases
including a pulmonary glomangiosarcoma: a clinico-
pathologic study with literature review. Am J Surg
Pathol 2000; 24: 1105–14.
5. Haque S, Modlin IM, West AB. Multiple glomus
tumors of the stomach with intravascular spread. Am J
Surg Pathol 1992; 16: 291–9.
6. Gould EW, Manivel JC, Albores-Saavedra J, Monforte
H. Locally infiltrative glomustumorsand glomangio-
sarcomas. Cancer 1990; 65: 310–8.
7. Kirshbaum GB, Teitelman SL. Malignant tumor of
the greater omentum simulating a glomangiosarcoma.
Arch Pathol 1939; 27: 95.
8. Lumley JS, Stansfeld AG. Infiltrating glomus tumor of
lower limb. Br Med J 1972; 1: 484–5.
9. Anagnostou GD, Papademetriou DG, Toumazani
MN. Subcutaneousglomustumor. Surg Gynecol
Obstet 1973; 136: 945–50.
10. SymmersWSC. Glomustumor (Letter to the editor).
Br Med J 1973; April 7: 50.
11. Mackay B, Legha SS, Pickler GM. Coin lesion of the
lung in a 19-year-old male. Ultrastruct Pathol 1981; 2:
289–94.
12. Kreutz RW, Christensen REJ. Glomangiosarcoma
with metastases to the maxilla. Int J Oral Maxillofac
Surg 1987; 16: 116–8.
13. Perez-Alfonso R, Hevia Y, Planas-Giron G. Atypical
glomustumor. Report of a cas e. Med Cutan Ibero Lat
Am 1987; 15: 256–8.
14. Aiba M, Hirayama A, Kuramochi S. Glomangio-
sarcoma in a glomus tumor: an immunohistochemical
and ultrastructural study. Cancer 1988; 61: 1467–71.
15. Noer H, Krogdahl A. Glomangiosarcoma of the lower
extremity. Histopathology 1991; 18: 365–6.
16. Daskalopoulou D, Maounis N, Kokalis G,
Liodandonaki P, Belezini E, Markidou S. The role of
fine needle aspiration cytology in the diagnosis of
primary skin tumors. Arch Anat Cytol Pathol 1993; 41:
75–81.
17. Watanabe K, Hoshi N, Tsu-Ura Y, Suzuki T. A case
of glomangiosarcoma. Fukushima J Med Sci 1995; 41:
71–7.
18. Brathwaite CD, Poppiti RJ. Malignant glomustumor.
A case report of widespread metastases in a patient
with multiple glomusbody hamartomas . Am J Surg
Pathol 1996; 20: 233–8.
19. Hiruta N, Kameda N, Tokudome T, Tsuchiya K,
Nonaka H, Hatori T, Akima M, Miura M. Malignant
glomustumor: a cas e report and review of the
literature. Am J Surg Pathol 1997; 21: 1096–103.
20. Lopez-RiosF, Rodriguez-Peralto JL, Cas tano E,
Ballestin C. Glomangiosarcoma of the lower limb:
a case report with a literature review. J Cutan Pathol
1997; 24: 571–4.
21. Wetherington RW, Lyle WG, Sangueza OP.
Malignant glomustumor of the tumb: a cas e report.
J Hand Surg Am 1997; 22: 1098–102.
22. Watanabe K, Sugino T, Kusakabbe T, Suzuki T.
Glomangiosarcoma of the hip: a report of a highly
aggressive tumor with widespread metastases. Br J
Dermatol 1998; 139: 1097–101.
23. Gaertner E, Steinberg DM, Huber M, Hayashi T,
Tsuda N, Askin FB, Bell SW, Nguyen B, Colby TV,
Nishimura SL, Miettinen M, Travis WD. Pulmonary
and mediastinal glomus tumors. Report of five cases
including a pulmonary glomangiosarcoma: a clinico-
90 A. De Chiara et al.pathologic study with literature review. Am J Surg
Pathol 2000; 24: 1105–14.
24. Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss
SW. Atypical and malignant glomus tumors: analysis
of 52 cases, with a proposal for the reclassification of
glomustumors . Am J Surg Pathol 2001; 25: 1–12.
25. Pulitzer DR, Martin PC, Reed RJ. Epithelioid Glomus
tumor. Hum Pathol 1995; 26: 1022–7.
26. Hegyi L, Cormack GC, Grant JW. Histochemical
investigation into the molecular mechanisms of
malignant transformation in a benign glomus tumor.
J Clin Pathol 1998; 51: 872–4.
27. Ogawa K, Oguchi M, Yamabe H, Nakashima Y,
Mamashima Y. Distribution of collagen IV in soft
tissue tumors. An immunohistochemical study. Cancer
1986; 58: 269–77.
Malignant glomus tumour 91Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com